A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.
C. Raymond Larkin, Jr. net worth and biography

C. Larkin, Jr. Biography and Net Worth

Director of Align Technology
C. Raymond Larkin, Jr., has served as a director of Align Technology since March 2004. In February 2006, Mr. Larkin was appointed as Chairman of the Board. He currently serves as a principal of Group Outcome L.L.C., a merchant banking firm concentrating on medical technologies. From 2001 to 2007, he served as a part time Venture Partner at Cutlass Capital, a venture capital firm. Prior to Group Outcome, Mr. Larkin was Chairman and CEO at Eunoe Inc., an investigative device for slowing and stopping progression of Alzheimer's disease. Prior to that, he was President and Chief Executive Officer of Nellcor Puritan Bennett, Inc., one of the world's preeminent respiratory products companies. Under Mr. Larkin's leadership over 15 years, Nellcor grew to nearly $1 billion in revenues through the development and introduction of pulse oximetry into worldwide use for patient safety monitoring, setting the standard of care for the respiratory-impaired patient. Mr. Larkin also held positions of increasing responsibility at Bentley Laboratories/American Hospital Supply from 1976 to 1983. He serves on the board of directors of Heartware, Inc., a medical device company developing implant devices for the treatment of advanced heart failure. Mr. Larkin received his B.S. degree in Industrial Management from LaSalle University.

What is C. Raymond Larkin, Jr.'s net worth?

The estimated net worth of C. Raymond Larkin, Jr. is at least $3.91 million as of May 13th, 2022. Larkin, Jr. owns 18,190 shares of Align Technology stock worth more than $3,909,577 as of October 3rd. This net worth approximation does not reflect any other investments that Larkin, Jr. may own. Learn More about C. Raymond Larkin, Jr.'s net worth.

How do I contact C. Raymond Larkin, Jr.?

The corporate mailing address for Larkin, Jr. and other Align Technology executives is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. Align Technology can also be reached via phone at (408) 470-1000 and via email at [email protected] Learn More on C. Raymond Larkin, Jr.'s contact information.

Has C. Raymond Larkin, Jr. been buying or selling shares of Align Technology?

C. Raymond Larkin, Jr. has not been actively trading shares of Align Technology during the last quarter. Most recently, on Friday, May 13th, C Raymond Larkin, Jr. bought 1,000 shares of Align Technology stock. The stock was acquired at an average cost of $264.42 per share, with a total value of $264,420.00. Following the completion of the transaction, the director now directly owns 18,190 shares of the company's stock, valued at $4,809,799.80. Learn More on C. Raymond Larkin, Jr.'s trading history.

Who are Align Technology's active insiders?

Align Technology's insider roster includes Simon Beard (Director), Kevin Burns (CFO), Julie Coletti (SVP), Robert Fitzgerald (Director), Stuart Hockridge (SVP), Joseph Hogan (CEO), Joseph Lacob (Director), C. Larkin, Jr. (Director), John Morici (CFO), George Morrow (Director), Thomas Prescott (Director), Vamsi Pudipeddi (CMO), Zelko Relic (SVP), Andrea Saia (Director), Yuval Shaked (SVP), Julie Tay (SVP), Warren Thaler (Director), and Emory Wright (SVP). Learn More on Align Technology's active insiders.

Are insiders buying or selling shares of Align Technology?

During the last year, Align Technology insiders bought shares 2 times. They purchased a total of 7,700 shares worth more than $2,264,236.00. During the last year, insiders at the medical equipment provider sold shares 2 times. They sold a total of 8,000 shares worth more than $5,612,540.00. The most recent insider tranaction occured on May, 13th when Director C Raymond Larkin Jr bought 1,000 shares worth more than $264,420.00. Insiders at Align Technology own 0.6 % of the company. Learn More about insider trades at Align Technology.

Information on this page was last updated on 5/13/2022.

C. Raymond Larkin, Jr. Insider Trading History at Align Technology

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/13/2022Buy1,000$264.42$264,420.0018,190View SEC Filing Icon  
7/29/2021Sell2,500$675.00$1,687,500.0018,667View SEC Filing Icon  
7/14/2021Sell2,500$650.00$1,625,000.00View SEC Filing Icon  
6/28/2021Sell5,000$621.73$3,108,650.0026,210View SEC Filing Icon  
5/7/2021Sell5,000$598.70$2,993,500.0030,987View SEC Filing Icon  
5/30/2019Sell9,734$296.65$2,887,591.1050,257View SEC Filing Icon  
5/7/2018Sell15,000$264.45$3,966,750.0097,922View SEC Filing Icon  
2/3/2017Sell15,000$94.71$1,420,650.0092,012View SEC Filing Icon  
5/5/2016Sell15,000$74.36$1,115,400.0085,260View SEC Filing Icon  
5/7/2015Sell15,000$59.03$885,450.00View SEC Filing Icon  
10/28/2014Sell15,000$51.54$773,100.00View SEC Filing Icon  
See Full Table

C. Raymond Larkin, Jr. Buying and Selling Activity at Align Technology

This chart shows C Raymond Larkin Jr's buying and selling at Align Technology by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Align Technology Company Overview

Align Technology logo
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Read More

Today's Range

Now: $215.65
Low: $206.88
High: $217.32

50 Day Range

MA: $257.02
Low: $207.11
High: $293.89

2 Week Range

Now: $215.65
Low: $204.32
High: $713.33


1,051,489 shs

Average Volume

964,807 shs

Market Capitalization

$16.84 billion

P/E Ratio


Dividend Yield